Approval · Notice of Compliance 31451 · 2023
TULIEVE: Notice of Compliance 31451
Issued August 21, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31451
- Date
- August 21, 2023
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative - Change in brand name
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TULIEVE | 02505401 | Dormant |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML